PhRMA Foundation Recognizes Three Trainees for Genetic Medicine Papers in Pharmaceutical Research

The PhRMA Foundation is recognizing three researchers with a $5,000 Trainee Challenge Award for their first-author papers published in the journal Pharmaceutical Research.

Through its Challenge Award program, the Foundation encourages early-career investigators to engage on emerging research topics and amplify their voices through publication in peer-reviewed journals.

This Challenge Award theme, “Advancing Genetic Medicine: Discovery, Development, and Delivery,” invited original research articles and review papers addressing advances and ongoing challenges across the genetic medicine ecosystem, including gene therapy, gene editing, and RNA-based therapeutics.

The Foundation is recognizing three first-author trainees whose manuscripts were published following peer review by Pharmaceutical Research:

• Genetic Medicine Approaches for Tumor Suppressor Loss: Therapeutic Replacement with Self-Amplifying RNA, Devin Mutha, Chaithanya P. Vedula, Sanjana Bhagavatula, Mark W. Grinstaff, Wilson W. Wong, Dan Lu, Neil J. Ganem and Rachel L. Flynn
• Mechanistic Insights into Poloxamer 188-Mediated Stabilization of AAV8 Capsids Using Coarse-Grained Molecular Dynamics, Leila Sharifi, Jahanbakhsh Ghasemi, Leo Santisi, Shivangi Naik, Willow DiLuzio, Arani Chanda and Bodhisattwa Chaudhuri
• Stimulus-Responsive Polymeric Carriers for Gene Delivery: Balancing Endosomal Escape with Nucleic Acid Release, Kenneth Hulugalla, Alexander W. Fortenberry, Dilusha J. de Silva and Thomas Werfel

About the PhRMA Foundation

The PhRMA Foundation is a 501(c)(3) nonprofit organization that fosters biopharmaceutical innovation and value-driven health care by investing in the frontiers of research. The Foundation catalyzes the careers of promising researchers through competitive, peer-reviewed grants and fellowships in the fields of drug delivery, drug discovery, translational medicine, and value assessment and health outcomes research.